Journal
FUTURE MEDICINAL CHEMISTRY
Volume 4, Issue 1, Pages 33-50Publisher
FUTURE SCI LTD
DOI: 10.4155/FMC.11.167
Keywords
-
Categories
Funding
- NIH (National Cancer Institute and National Institute of General Medical Sciences) in the USA
- NATIONAL CANCER INSTITUTE [R01CA103314] Funding Source: NIH RePORTER
Ask authors/readers for more resources
A long-standing problem of conventional cancer chemotherapy is the lack of tumor specificity. Tumor-targeting drug-delivery systems have been explored to overcome this problem. These systems combine a powerful cytotoxic anticancer agent with a tumor-targeting molecule via a 'smart' linker to form highly efficacious drug conjugates. These drug conjugates can deliver potent cytotoxic drugs specifically to tumors and tumor cells with minimal systemic toxicity. This review describes our groups' research on the molecular approaches to the design and development of a novel drug-delivery system bearing highly potent new-generation taxoids for tumor-targeting chemotherapy in our laboratory.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available